{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:39:02Z","timestamp":1786718342024,"version":"build-2736575974"},"reference-count":49,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Experimental evidence has shown that gallic acid (GA), a naturally occurring polyphenolic compound, and docetaxel (DTX), a taxane chemotherapeutic agent, each possess antitumor activity against multiple cancer types. Although both compounds have been investigated individually, their combined effects in triple-negative breast cancer (TNBC) have received limited attention, and the molecular basis of their interaction remains unclear. The present study examined the in vitro effects of GA and DTX in MDA-MB-231 TNBC cells while simultaneously assessing their comparative cytotoxicity in HaCaT human keratinocytes. Evaluation of treatment efficacy included measurement of cell viability by the MTT assay and assessment of drug interactions using the Chou\u2013Talalay combination index (CI) method. Apoptosis together with cell-cycle distribution was subsequently examined using both Annexin V\/PI flow cytometry and TALI\u00ae image-based cytometry. Additional analyses included \u03b2-tubulin immunofluorescence (IF), caspase-9 immunocytochemistry, ELISA, wound-healing assays, quantitative real-time PCR, and bioinformatic analyses to investigate treatment-associated biological alterations. Combined exposure to GA and DTX produced a significant reduction in cell viability and exhibited synergistic activity in MDA-MB-231 cells. The coordinated biological response to the combined treatment was characterized by increased apoptotic cell death, arrest of the cell cycle at the G2\/M phase, extensive disorganization of the \u03b2-tubulin network, and enhanced caspase-9 immunoreactivity. Beyond its effects on cell survival, the combined regimen substantially decreased the release of IL-6, IL-8, and TNF-\u03b1, limited wound-healing capacity, and reshaped the expression profile of the apoptosis- and cell cycle-related genes BCL2, BAX, CASP9, and CDKN1A. Bioinformatic analyses further revealed enrichment of apoptosis- and cell-cycle-associated pathways that were generally consistent with the experimental observations. The overall pattern of experimental responses indicates that combining GA with DTX enhances the in vitro antitumor efficacy of DTX in TNBC cells by simultaneously influencing apoptotic pathways, cell-cycle regulation, inflammatory cytokine secretion, and cellular migratory capacity. Although the bioinformatic findings provide supportive hypothesis-generating evidence, additional studies using three-dimensional models, in vivo experiments, and functional validation approaches are necessary to confirm the underlying molecular mechanisms and to further define the translational potential of this therapeutic combination.<\/jats:p>","DOI":"10.3390\/biology15141131","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:28:27Z","timestamp":1783927707000},"page":"1131","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gallic Acid Enhances the Anticancer Activity of Docetaxel in Triple-Negative Breast Cancer Cells"],"prefix":"10.3390","volume":"15","author":[{"given":"Mehmet Emin","family":"Aya\u011f","sequence":"first","affiliation":[{"name":"Mehmet Emin Aya\u011f Practice, Department of Gynecology and Obstetrics, 47000 Mardin, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7317-5467","authenticated-orcid":false,"given":"Mehmet Cudi","family":"Tuncer","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Faculty of Medicine, Dicle University, 21280 Diyarbak\u0131r, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lhan","family":"\u00d6zdemir","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Faculty of Medicine, Kahramanmara\u015f S\u00fct\u00e7\u00fc \u0130mam University, 46000 Kahramanmara\u015f, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer-Expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_3","first-page":"106","article-title":"Current approaches in treatment of triple-negative breast cancer","volume":"12","author":"Wahba","year":"2015","journal-title":"Cancer Biol. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1470-2045(05)70094-2","article-title":"Docetaxel for treatment of solid tumours: A systematic review of clinical data","volume":"6","author":"Montero","year":"2005","journal-title":"Lancet Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1634\/theoncologist.9-suppl_2-24","article-title":"Docetaxel and paclitaxel in the treatment of breast cancer: A review of clinical experience","volume":"9","author":"Crown","year":"2004","journal-title":"Oncologist"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/oxfordjournals.annonc.a010544","article-title":"A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: Report of the Clinical Screening Group of the EORTC","volume":"7","author":"Fumoleau","year":"1996","journal-title":"Ann. Oncol."},{"key":"ref_7","first-page":"225","article-title":"Pharmacological effects of gallic acid in health and diseases: A mechanistic review","volume":"22","author":"Kahkeshani","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hadidi, M., Li\u00f1\u00e1n-Atero, R., Tarahi, M., Christodoulou, M.C., and Aghababaei, F. (2024). The Potential Health Benefits of Gallic Acid: Therapeutic and Food Applications. Antioxidants, 13.","DOI":"10.3390\/antiox13081001"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3892\/ol.2013.1632","article-title":"Gallic acid reduces cell viability, proliferation, invasion and angiogenesis in human cervical cancer cells","volume":"6","author":"Zhao","year":"2013","journal-title":"Oncol. Lett."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Sar\u0131, U., Zaman, F., \u00d6zdemir, \u0130., \u00d6zt\u00fcrk, \u015e., and Tuncer, M.C. (2024). Gallic Acid Induces HeLa Cell Lines Apoptosis via the P53\/Bax Signaling Pathway. Biomedicines, 12.","DOI":"10.3390\/biomedicines12112632"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.tiv.2010.04.009","article-title":"Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase","volume":"24","author":"You","year":"2010","journal-title":"Toxicol. Vitr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.canlet.2009.05.040","article-title":"Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate cancer cells","volume":"286","author":"Chen","year":"2009","journal-title":"Cancer Lett."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: Advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_14","first-page":"327","article-title":"Inhibitory effect of Curcumin on a cervical cancer cell line via the RAS\/RAF signaling pathway","volume":"40","author":"Zaman","year":"2025","journal-title":"Histol. Histopathol."},{"key":"ref_15","first-page":"1415","article-title":"Rosmarinic acid inhibits the proliferation of ovarian carcinoma cells by activating the p53\/BAX signaling pathway","volume":"40","author":"Tuncer","year":"2025","journal-title":"Histol. Histopathol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Duman, E., Ma\u00e7in, A., \u00d6zdemir, \u0130., \u00d6zt\u00fcrk, \u015e., and Tuncer, M.C. (2026). Synergistic Antitumor Effects of Rosmarinic Acid and Cisplatin in Retinoblastoma: Evidence from 2D and 3D Tumor Models. Biomedicines, 14.","DOI":"10.3390\/biomedicines14030602"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"\u00c7avu\u015f, Y., Alkan Akal\u0131n, S., Af\u015fin, Y., Toprak, V., \u00d6zdemir, \u0130., Tuncer, M.C., and \u00d6zt\u00fcrk, \u015e. (2026). Synergistic Antitumor Effects of Etoposide and Curcumin in Ovarian Cancer Cells. Biomedicines, 14.","DOI":"10.3390\/biomedicines14030509"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13167-021-00242-5","article-title":"Flavonoids as an effective sensitizer for anti-cancer therapy: Insights into multi-faceted mechanisms and applicability towards individualized patient profiles","volume":"12","author":"Liskova","year":"2021","journal-title":"EPMA J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10637-009-9241-9","article-title":"Chemopreventive efficacy of gallic acid, an antioxidant and anticarcinogenic polyphenol, against 1,2-dimethyl hydrazine induced rat colon carcinogenesis","volume":"28","author":"Giftson","year":"2010","journal-title":"Investig. New Drugs"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","article-title":"Role of interleukin-6 in cancer progression and therapeutic resistance","volume":"37","author":"Kumari","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.onc.1206113","article-title":"IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells","volume":"22","author":"Freund","year":"2003","journal-title":"Oncogene"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: Mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.cell.2019.04.024","article-title":"The coming decade of cell death research: Five riddles","volume":"177","author":"Green","year":"2019","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yuan, F., Pan, X., Chen, L., Zhang, Y.H., Huang, T., and Cai, Y.D. (2019). Analysis of Protein-Protein Functional Associations by Using Gene Ontology and KEGG Pathway. Biomed. Res. Int., 2019.","DOI":"10.1155\/2019\/4963289"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1134\/S1607672924601276","article-title":"Gallic Acid Enhances Cisplatin-induced Death of Human Laryngeal Cancer Cells by Activating the TRPM2 Channel","volume":"521","author":"Yazgan","year":"2025","journal-title":"Dokl. Biochem. Biophys."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.54457\/DR.202402015","article-title":"Multifaced Anticancer Potential of Doxorubicin: Spotlight on Breast Cancer","volume":"5","author":"Swain","year":"2025","journal-title":"Dis. Res."},{"key":"ref_27","first-page":"3007","article-title":"Gallic acid sensitizes paclitaxel-resistant human ovarian carcinoma cells through an increase in reactive oxygen species and subsequent downregulation of ERK activation","volume":"39","author":"Nieto","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/sj.onc.1202305","article-title":"Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells","volume":"18","author":"Shtil","year":"1999","journal-title":"Oncogene"},{"key":"ref_29","first-page":"613950","article-title":"Gallic Acid Induces a Reactive Oxygen Species-Provoked c-Jun NH2-Terminal Kinase-Dependent Apoptosis in Lung Fibroblasts","volume":"2013","author":"Chen","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1021\/jf9043265","article-title":"Gallic acid induces apoptosis of lung fibroblasts via a reactive oxygen species-dependent ataxia telangiectasia mutated-p53 activation pathway","volume":"58","author":"Chuang","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.10-90003-20","article-title":"Extending survival with chemotherapy in metastatic breast cancer","volume":"10","year":"2005","journal-title":"Oncologist"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.6004\/jnccn.2013.0098","article-title":"Breast cancer, version 3.2013: Featured updates to the NCCN guidelines","volume":"11","author":"Theriault","year":"2013","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.biochi.2014.10.001","article-title":"Inhibition of autophagy by chloroquine potentiates synergistically anti-cancer property of artemisinin by promoting ROS dependent apoptosis","volume":"107","author":"Ganguli","year":"2014","journal-title":"Biochimie"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"100742","DOI":"10.1016\/j.drup.2020.100742","article-title":"Taxanes in cancer treatment: Activity, chemoresistance and its overcoming","volume":"54","author":"Mosca","year":"2021","journal-title":"Drug Resist. Updat."},{"key":"ref_35","first-page":"1","article-title":"The role of cytokines in breast cancer development and progression","volume":"35","author":"Castro","year":"2015","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1158\/0008-5472.CAN-12-4524-T","article-title":"Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8","volume":"73","author":"Hartman","year":"2013","journal-title":"Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Wang, X., Decker, C.C., Zechner, L., Krstin, S., and Wink, M. (2019). In vitro wound healing of tumor cells: Inhibition of cell migration by selected cytotoxic alkaloids. BMC Pharmacol. Toxicol., 20.","DOI":"10.1186\/s40360-018-0284-4"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/j.1349-7006.2010.01540.x","article-title":"Docetaxel suppresses invasiveness of head and neck cancer cells in vitro","volume":"101","author":"Kogashiwa","year":"2010","journal-title":"Cancer Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11010-011-0900-8","article-title":"Gallic acid-induced lung cancer cell death is accompanied by ROS increase and glutathione depletion","volume":"357","author":"You","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.semcancer.2019.05.012","article-title":"Role of the PI3K\/AKT\/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance","volume":"59","author":"Ediriweera","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.1158\/1078-0432.CCR-18-1541","article-title":"EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung Adenocarcinomas","volume":"24","author":"Jorge","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_43","first-page":"2783","article-title":"Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies","volume":"24","author":"Aggarwal","year":"2004","journal-title":"Anticancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.106.3.761","article-title":"Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line","volume":"106","author":"Boukamp","year":"1988","journal-title":"J. Cell Biol."},{"key":"ref_45","first-page":"1276","article-title":"HaCaT cells as a model system to study primary cilia in keratinocytes","volume":"31","author":"Blanchard","year":"2022","journal-title":"Exp. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10555-008-9129-8","article-title":"MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: Properties and expression in cancer","volume":"27","author":"Sohail","year":"2008","journal-title":"Cancer Metastasis Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"114068","DOI":"10.1016\/j.foodres.2024.114068","article-title":"Dietary gallic acid as an antioxidant: A review of its food industry applications, health benefits, bioavailability, nano-delivery systems, and drug interactions","volume":"180","author":"Xiang","year":"2024","journal-title":"Food Res. Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"110985","DOI":"10.1016\/j.biopha.2020.110985","article-title":"Gallic acid: Pharmacological activities and molecular mechanisms involved in inflammation-related diseases","volume":"133","author":"Bai","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Park, W.H. (2026). The Evolving Therapeutic Landscape of Gallic Acid: A Review of Mechanistic Insights and Clinical Potential. Mol. Nutr. Food Res., 70.","DOI":"10.1002\/mnfr.70491"}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/15\/14\/1131\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:47:00Z","timestamp":1783928820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/15\/14\/1131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":49,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["biology15141131"],"URL":"https:\/\/doi.org\/10.3390\/biology15141131","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]}}}